Bionano Genomics, Inc. (BNGO)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$1.19
-3.25%
Mkt Cap $3.68M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $7.88M | $7.95M | +0.91% | -$0.81 | -$0.03 | +96.30% | — | — |
| Q4 2025 Nov 13, 2025 | $7.90M | $7.37M | -6.75% | -$1.81 | -$1.59 | +12.15% | — | — |
| Q3 2025 Aug 14, 2025 | $7.22M | $6.73M | -6.78% | -$2.69 | -$1.99 | +26.02% | — | — |
| Q2 2025 May 14, 2025 | $6.25M | $6.46M | +3.31% | -$3.49 | -$1.15 | +67.05% | — | — |
| Q1 2025 Mar 31, 2025 | $6.20M | $8.16M | +31.66% | -$6.00 | -$57.49 | -858.17% | — | — |
| Q4 2024 Nov 14, 2024 | $6.30M | $6.07M | -3.60% | -$0.21 | -$19.16 | -9023.81% | — | — |
| Q3 2024 Aug 7, 2024 | $6.30M | $7.77M | +23.35% | -$0.42 | -$14.37 | -3321.43% | — | — |
| Q2 2024 May 8, 2024 | $10.72M | $8.77M | -18.21% | -$0.64 | -$35.93 | -5514.06% | — | — |
| Q1 2024 Mar 5, 2024 | $10.58M | $10.72M | +1.33% | -$0.87 | -$57.49 | -6508.05% | — | — |
| Q4 2023 Nov 8, 2023 | $10.54M | $9.32M | -11.59% | -$44.91 | -$88.62 | -97.33% | — | — |
| Q3 2023 Aug 9, 2023 | $8.29M | $8.66M | +4.49% | -$53.89 | -$74.25 | -37.78% | — | — |
| Q2 2023 May 9, 2023 | $7.36M | $7.42M | +0.75% | -$53.89 | -$71.86 | -33.35% | — | — |
| Q1 2023 Mar 9, 2023 | $8.00M | $8.21M | +2.69% | -$53.89 | -$77.84 | -44.44% | — | — |
| Q4 2022 Nov 3, 2022 | $6.79M | $7.22M | +6.28% | -$71.86 | -$65.87 | +8.34% | — | — |
| Q3 2022 Aug 4, 2022 | $6.28M | $6.67M | +6.16% | -$59.88 | -$65.87 | -10.00% | — | — |
| Q2 2022 May 5, 2022 | $5.70M | $5.70M | -0.12% | -$47.90 | -$65.87 | -37.52% | — | — |
| Q1 2022 Mar 1, 2022 | $5.57M | $6.30M | +13.09% | -$41.92 | -$47.90 | -14.27% | — | — |
| Q4 2021 Nov 4, 2021 | $4.23M | $4.66M | +10.05% | -$35.93 | -$41.92 | -16.67% | — | — |
| Q3 2021 Aug 4, 2021 | $3.86M | $3.86M | +0.00% | -$29.94 | -$35.93 | -20.01% | — | — |
| Q2 2021 May 13, 2021 | $3.17M | $3.17M | +0.00% | -$29.94 | -$29.94 | +0.00% | — | — |